bexionpharma.com
Bexion Pharmaceuticals and CTI Clinical Trial and Consulting Services Announce Completion of First-in-Human Trial Using BXQ-350 for the Treatment of Cancer
Covington, KY - Bexion Pharmaceuticals (Bexion) and CTI Clinical Trial and Consulting Services (CTI) announce the successful completion of the First-in-Human Phase IA clinical trial with BXQ-350 for the treatment of cancer. This dose escalation, open-label study included adult patients with advanced solid tumors. “We are very excited to have successfully completed this First-in-Human, dose escalation trial